A Randomized, Double Blind, Controlled Versus Placebo in Parallel Groups, Study to Evaluate the Efficacy of 10 mg Lyophilized Oral Rizatriptan in the Acute Treatment of Migraine in Patients With Unilateral Trigeminal Autonomic Symptoms.

Trial Profile

A Randomized, Double Blind, Controlled Versus Placebo in Parallel Groups, Study to Evaluate the Efficacy of 10 mg Lyophilized Oral Rizatriptan in the Acute Treatment of Migraine in Patients With Unilateral Trigeminal Autonomic Symptoms.

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Mar 2013

At a glance

  • Drugs Rizatriptan (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Mar 2012 Actual initiation date changed from 1 Jul 2009 to 25 Jun 2009 as reported by European Clinical Trials Database.
    • 20 Mar 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2008-007967-18).
    • 11 Oct 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top